ArticleEye (London, England)2026

Pharmacokinetic and pharmacodynamic considerations of cumulative intravitreal drug exposure of the newer anti-VEGF agents.

Petros AristodemouPubMed ↗Publisher ↗

No numbers read from the abstract.